Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The operating income for PepGen Inc. as of June 30, 2025 is -102.77 MM.
- The net income for PepGen Inc. as of June 30, 2025 is -96.92 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -102.77 | -96.92 | |
2025-03-31 | -109.26 | -102.16 | |
2024-12-31 | -97.74 | -89.98 | |
2024-09-30 | -94.20 | -87.23 | |
2024-06-30 | -95.81 | -89.14 | |
2024-03-31 | -86.53 | -80.33 | |
2023-12-31 | -84.77 | -78.63 | |
2023-09-30 | -81.17 | -74.07 | |
2023-06-30 | -75.94 | -69.38 | |
2023-03-31 | -72.44 | -67.18 | |
2022-12-31 | -68.30 | -69.10 | |
2022-09-30 | -58.30 | -61.31 | |
2022-06-30 | -46.82 | -50.82 | |
2022-03-31 | -34.37 | -38.89 | |
2021-12-31 | -27.11 | -27.28 | |
2021-09-30 | -20.69 | -20.93 | |
2021-06-30 | -12.95 | -13.16 | |
2021-03-31 | -8.13 | -8.15 | |
2020-12-31 | -1.88 | -1.89 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -3.14 | -3.14 |
2024-12-31 | -2.85 | |
2024-09-30 | -2.97 | -2.97 |
2024-06-30 | -3.28 | -3.28 |
2024-03-31 | -3.21 | -3.21 |
2023-12-31 | -3.30 | |
2023-09-30 | -3.12 | -3.12 |
2023-06-30 | -2.92 | -2.92 |
2023-03-31 | -3.15 | -3.15 |
2022-12-31 | -4.42 | |
2022-09-30 | -6.16 | -6.16 |
2022-06-30 | -12.00 | -12.00 |
2022-03-31 | -42.34 | -42.35 |
2021-12-31 | -30.27 | |
2021-09-30 | -25.96 | -25.96 |
2021-06-30 | -17.37 | -17.37 |
2021-03-31 | -11.79 | -11.79 |
2020-12-31 | -4.69 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for PepGen Inc. as of June 30, 2025 is -90.02 MM.
- The cash from investing activities for PepGen Inc. as of June 30, 2025 is 58.47 MM.
- The cash from financing activities for PepGen Inc. as of June 30, 2025 is 0.55 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -90.02 | 58.47 | 0.55 |
2025-03-31 | -82.77 | -9.23 | 1.78 |
2024-12-31 | -82.37 | -37.67 | 88.75 |
2024-09-30 | -82.32 | -93.76 | 88.65 |
2024-06-30 | -74.99 | -93.85 | 87.99 |
2024-03-31 | -76.11 | -42.11 | 86.65 |
2023-12-31 | -69.00 | -32.00 | -0.19 |
2023-09-30 | -62.96 | -3.52 | 0.00 |
2023-06-30 | -67.24 | -3.72 | -1.09 |
2023-03-31 | -62.41 | -3.32 | 112.34 |
2022-12-31 | -59.27 | -3.75 | 112.19 |
2022-09-30 | -51.86 | -2.81 | 110.95 |
2022-06-30 | -38.55 | -2.40 | 245.24 |
2022-03-31 | -32.04 | -1.81 | 147.64 |
2021-12-31 | -22.60 | -0.50 | 147.66 |
2021-09-30 | -16.70 | -0.35 | 156.64 |
2021-06-30 | -9.77 | -0.33 | 23.77 |
2021-03-31 | -4.06 | -0.31 | 7.95 |
2020-12-31 | -1.65 | -0.01 | 7.95 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for PepGen Inc. as of June 30, 2025 is -0.36.
- The p/book for PepGen Inc. as of June 30, 2025 is 0.40.
- The p/tbv for PepGen Inc. as of June 30, 2025 is 0.40.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -0.36 | 0.40 | 0.40 |
2025-03-31 | 0.41 | 0.41 | |
2024-12-31 | 0.91 | 0.91 | |
2024-09-30 | -3.22 | 1.85 | 1.85 |
2024-06-30 | -6.64 | 2.98 | 2.98 |
2024-03-31 | -5.80 | 4.20 | 4.20 |
2023-12-31 | -2.23 | 1.31 | 1.31 |
2023-09-30 | -1.74 | 0.82 | 0.82 |
2023-06-30 | -3.46 | 1.41 | 1.41 |
2023-03-31 | -4.21 | 1.62 | |
2022-12-31 | 1.64 | 1.64 | |
2022-09-30 | 1.01 | 1.01 | |
2022-06-30 | -6.02 | 2.02 | 2.02 |
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for PepGen Inc. as of June 30, 2025 is 14.38.
- The ebit (3y)/ev for PepGen Inc. as of June 30, 2025 is 12.21.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | 14.38 | 12.21 |
2025-03-31 | 87.43 | 76.80 |
2024-12-31 | -1.06 | -0.93 |
2024-09-30 | -0.71 | -0.58 |
2024-06-30 | -0.20 | -0.15 |
2024-03-31 | -0.21 | -0.15 |
2023-12-31 | -2.09 | -1.42 |
2023-09-30 | 2.69 | 1.66 |
2023-06-30 | -1.02 | -0.64 |
2023-03-31 | -0.60 | -0.33 |
2022-12-31 | -0.47 | -0.22 |
2022-09-30 | 7.29 | 3.53 |
2022-06-30 | -0.12 | -0.06 |
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 |
Management Effectiveness
- The roa for PepGen Inc. as of June 30, 2025 is -0.53.
- The roe for PepGen Inc. as of June 30, 2025 is -0.66.
- The roic for PepGen Inc. as of June 30, 2025 is -0.93.
- The croic for PepGen Inc. as of June 30, 2025 is -0.82.
- The ocroic for PepGen Inc. as of June 30, 2025 is -0.75.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | -0.53 | -0.66 | -0.93 | -0.82 | -0.75 |
2025-03-31 | -0.43 | -0.50 | -0.66 | -0.23 | -0.60 |
2024-12-31 | -0.61 | -0.80 | -0.56 | -0.56 | -0.53 |
2024-09-30 | -0.54 | -0.71 | -0.51 | -0.46 | -0.43 |
2024-06-30 | -0.40 | -0.49 | -0.40 | -0.16 | -0.38 |
2024-03-31 | -0.36 | -0.44 | -0.61 | -0.79 | -0.54 |
2023-12-31 | -0.36 | -0.38 | -0.51 | -0.45 | -0.43 |
2023-09-30 | -0.30 | -0.33 | -0.41 | -0.43 | -0.40 |
2023-06-30 | -0.29 | -0.32 | -0.41 | -0.43 | -0.40 |
2023-03-31 | -0.52 | -0.60 | -0.36 | 0.25 | -0.33 |
2022-12-31 | -0.41 | -0.44 | -0.32 | 0.29 | -0.27 |
2022-09-30 | -0.34 | -0.36 | -0.32 | 0.29 | -0.27 |
2022-06-30 | -1.97 | -2.68 | -0.24 | 0.97 | -0.18 |
2022-03-31 | -1.97 | -3.97 | -0.34 | 0.98 | -0.28 |
2021-12-31 | -2.56 | -2.78 | -0.20 | 0.93 | -0.17 |
2021-09-30 | -0.15 | 1.00 | -0.12 | ||
2021-06-30 | -3.14 | -3.40 | -0.91 | 0.96 | -0.67 |
2021-03-31 | -1.79 | -1.95 | -0.83 | 0.38 | -0.39 |
2020-12-31 | -0.45 | -0.49 | -0.19 | 0.64 | -0.17 |
Gross Margins
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Identifiers and Descriptors
Central Index Key (CIK) | 1835597 |
Industry Groups
SIC 2834 - Pharmaceutical Preparations |